Genetic polymorphisms of PIP5K2A and course of schizophrenia

Abstract Background Schizophrenia is a severe highly heritable mental disorder. The clinical heterogeneity of schizophrenia is expressed in the difference in the leading symptoms and course of the disease. Identifying the genetic variants that affect clinical heterogeneity may ultimately reveal the...

Full description

Saved in:
Bibliographic Details
Main Authors: Evgeniya G. Poltavskaya (Author), Olga Yu. Fedorenko (Author), Natalya M. Vyalova (Author), Elena G. Kornetova (Author), Nikolay A. Bokhan (Author), Anton J. M. Loonen (Author), Svetlana A. Ivanova (Author)
Format: Book
Published: BMC, 2020-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_f195867aa05b434b97a3cb19c314d873
042 |a dc 
100 1 0 |a Evgeniya G. Poltavskaya  |e author 
700 1 0 |a Olga Yu. Fedorenko  |e author 
700 1 0 |a Natalya M. Vyalova  |e author 
700 1 0 |a Elena G. Kornetova  |e author 
700 1 0 |a Nikolay A. Bokhan  |e author 
700 1 0 |a Anton J. M. Loonen  |e author 
700 1 0 |a Svetlana A. Ivanova  |e author 
245 0 0 |a Genetic polymorphisms of PIP5K2A and course of schizophrenia 
260 |b BMC,   |c 2020-10-01T00:00:00Z. 
500 |a 10.1186/s12881-020-01107-w 
500 |a 1471-2350 
520 |a Abstract Background Schizophrenia is a severe highly heritable mental disorder. The clinical heterogeneity of schizophrenia is expressed in the difference in the leading symptoms and course of the disease. Identifying the genetic variants that affect clinical heterogeneity may ultimately reveal the genetic basis of the features of schizophrenia and suggest novel treatment targets. PIP5K2A (Phosphatidylinositol-4-Phosphate 5-Kinase Type II Alpha) has been investigated as a potential susceptibility gene for schizophrenia. Methods In this work, we studied the possible association between eleven polymorphic variants of PIP5K2A and the clinical features of schizophrenia in a population of 384 white Siberian patients with schizophrenia. Genotyping was carried out on QuantStudio 5 Real-Time PCR System with a TaqMan Validate SNP Genotyping Assay (Applied Biosystems, USA). Results PIP5K2A rs8341 (χ2 = 6.559, p = 0.038) and rs946961 (χ2 = 5.976, p = 0.049) showed significant association with course of schizophrenia (continuous or episodic). The rs8341*CT (OR = 1.63, 95% CI: 1.04-2.54) and rs946961*CC (OR = 5.17, 95% CI: 1.20-22.21) genotypes were associated with a continuous type of course, while the rs8341*TT genotype (OR = 0.53, 95% CI: 0.29-0.97) was associated with an episodic type of course of schizophrenia. Therefore rs8341*TT genotype presumably has protective effect against the more severe continuous course of schizophrenia compared to the episodic one. Conclusions Our experimental data confirm that PIP5K2A is a genetic factor influencing the type of course of schizophrenia in Siberian population. Disturbances in the phosphatidylinositol pathways may be a possible reason for the transition to a more severe continuous course of schizophrenia. 
546 |a EN 
690 |a Schizophrenia 
690 |a PIPK2A 
690 |a Genetic polymorphism 
690 |a Type of course 
690 |a Leading symptoms 
690 |a Internal medicine 
690 |a RC31-1245 
690 |a Genetics 
690 |a QH426-470 
655 7 |a article  |2 local 
786 0 |n BMC Medical Genetics, Vol 21, Iss S1, Pp 1-9 (2020) 
787 0 |n http://link.springer.com/article/10.1186/s12881-020-01107-w 
787 0 |n https://doaj.org/toc/1471-2350 
856 4 1 |u https://doaj.org/article/f195867aa05b434b97a3cb19c314d873  |z Connect to this object online.